Cimzia (Certolizumab pegol PFS) 200mg/ml

Cimzia (certolizumab pegol) is a prescription medication in a prefilled syringe (PFS) used for autoimmune conditions. It belongs to the TNF-alpha inhibitor class and is stored at 2-8°C. This 200mg/ml strength PFS is designed for convenient subcutaneous administration.

Strength

200mg/ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

UCB Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Certolizumab pegol is used to reduce symptoms and induce remission in autoimmune conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It may also be prescribed for moderate to severe Crohn’s disease or plaque psoriasis when other treatments are ineffective. Patients often ask, 'What is certolizumab pegol used for?' to understand its role in managing chronic inflammatory diseases.

Side Effects

This medication works by targeting specific proteins in the immune system to decrease inflammation. Users may notice reduced joint pain, swelling, or skin plaque over time. The effects vary by individual, and consistent use is often required to maintain benefits. Some patients report improved mobility and daily functioning as inflammation subsides.

Precautions & Warnings

Keep the prefilled syringe refrigerated at 2-8°C and protect it from light. Do not freeze or shake the syringe. Before use, allow it to reach room temperature for 30 minutes, but do not remove the needle cap during this time. Dispose of used syringes in a sharps container as directed by local regulations.

Avoid Interactions

Certolizumab pegol may interact with live vaccines, increasing infection risk, so avoid vaccinations during treatment. Combining it with other immunosuppressants (e.g., methotrexate) requires medical supervision due to heightened infection potential. Alcohol and certain supplements may also affect how the body processes the medication. Always inform your healthcare provider about all medications and supplements in use.

References

Frequently Asked Questions

It is given as a subcutaneous injection using a prefilled syringe, typically every 2 to 4 weeks. A healthcare professional may train you to self-inject if prescribed.

Common effects may include injection site reactions, headache, or upper respiratory infections. Serious infections or allergic reactions are rare but require immediate medical attention.

Certolizumab pegol is a prescription medication and cannot be purchased without a valid prescription from a licensed healthcare provider.

Pregnant individuals should discuss risks and benefits with their doctor, as certolizumab pegol may cross the placenta and affect the infant’s immune system.

Store the prefilled syringe in the refrigerator at 2-8°C. Do not freeze, and keep it away from direct light until ready to use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.